Elwha LLC

Avedro, Inc.

Summit Technology, Inc.

Identix Corporation

Morphotrust USA, LLC

Optos Plc

Scientific Generics Limited

Ellex R&d Pty Ltd

John Marshall

David Muller

Roderick A Hyde

Clarence T Tegreene

Roger Zaldivar

Roberto Zaldivar

Marc David Friedman

David Usher

Yasunari Tosa

Nicholas A Accomando

Pablo Casaverde

Tim McNerney

Lowell L Wood, Jr

Jordin T Kare

David F Muller

Jesse R Cheatham, Iii

Katherine E Sharadin

Pavel Kamaev

Malcolm Plunkett

Ronald Scharf

Radha Pertaub

Don Yansen

Greg Heacock

Anthony Raven

Walter T Welford

Stephen Scharf

Gregory L Heacock

Aly Hussain

Ali Hussein

Lucia Pelosini

Anthony L Raven

Karen M Ness

Antony L Raven

Stephen Blinn

Embodiments disclosed herein relate to systems including at least one ophthalmic device and methods of using the system. The ophthalmic device includes at least one switchable lens therein that includes at least one electro-optical material. The ophthalmic device also includes at least one charging electrical circuitry. The charging electrical circuitry is electrically coupled to the switchable lens and is configured to receive electrical energy from or provide electrical energy to the switchable lens. The ophthalmic device can also include at least one transfer electrical circuitry that can be coupled to and configured to transfer electrical energy between the charging electrical circuitry and the switchable lens. The ophthalmic device can also include at least one controller operably coupled to at least the charging electrical circuitry and the transfer electrical circuitry. The controller can be configured to at least partially control the charging electrical circuitry and the transfer electrical circuitry.

Ophthalmic devices and related methods

Embodiments disclosed herein are directed to switchable lens devices, systems, and methods related to detecting one or more commands and switching one or more switchable lenses responsive to one or more detected commands.

Switchable lens devices, systems, and related methods

Embodiments disclosed herein are directed to intraocular lens systems having a plurality of materials therein, with at least some of the materials having a diffraction pattern therein and an electrically-modifiable index of refraction collectively configured to selectively alter an effective focal length of the intraocular lens system. Methods of modifying a focal length of an intraocular lens system are also disclosed.

Intraocular lens systems and related methods

Embodiments disclosed herein are directed to intraocular lens devices, systems, and methods that include determining relative tilt and/or vergence rotation of a subject's eyes and focusing one or more intraocular lenses based on the determined vergence rotation.

Intraocular lens devices, systems, and related methods

Embodiments disclosed herein are directed to intraocular lens systems includes at least one intraocular lens device and methods of using the same. The at least one intraocular lens device includes one or more photodetectors and an intraocular lens exhibiting a modifiable focal length. The one or more photodetectors are configured to detect light that is used to determine a presence of the object or the apparent object distance. The focal length of the intraocular lens can be modified depending on the determined presence of the object or the apparent object distance.

Embodiments disclosed herein are directed to intraocular lens systems having a plurality of materials therein, with at least some of the materials having a diffraction pattern therein and an electrically-modifiable index of refraction collectively configured to selectively alter the focal length of the intraocular lens system. Methods of modifying a focal length of an intraocular lens system are also disclosed.

Embodiments apply a cross-linking agent to a region of corneal tissue. The cross-linking agent improves the ability of the corneal tissue to resist undesired structural changes. For example, the cross-linking agent may be Riboflavin or Rose Bengal, and the initiating element may be photoactivating light, such as ultraviolet (UV) light. In these embodiments, the photoactivating light initiates cross-linking activity by irradiating the applied cross-linking agent to release reactive oxygen radicals in the corneal tissue. The cross-linking agent acts as a sensitizer to convert Ointo singlet oxygen which causes cross-linking within the corneal tissue. The rate of cross-linking in the cornea is related to the concentration of Opresent when the cross-linking agent is irradiated with photoactivating light. Accordingly, the embodiments control the concentration of Oduring irradiation to increase or decrease the rate of cross-linking and achieve a desired amount of cross-linking.

Eye therapy system

A multimodal biometric identification system captures and processes images of both the iris and the retina for biometric identification. Another multimodal ocular system captures and processes images of the iris and/or the from both eyes of a subject. Biometrics based on data provided by these systems are more accurate and robust than using biometrics that include data from only the iris or only the retina from a single eye. An exemplary embodiment emits photons to the iris and the retina of both eyes, an iris image sensor that captures an image of the iris when the iris reflects the emitted light, a retina image sensor that captures an image of the retina when the retina reflects the emitted light, and a controller that controls the iris and the retina illumination sources, where the captured image of the iris and the captured image of the retina contain biometric data.

Multimodal ocular biometric system

Eye therapy

A method of retinal regeneration which improves retinal function by reversal of the degradation of the transport properties of Bruch's membrane. The method involves irradiation through the cornea of the eye to the retinal pigmented epithelium by a laser pulse or sequence of laser pulses having a pulse duration in the range of 10 ps to 20 &#x3bc;s and at a wavelength in the range of about 500 nm to 900 nm. The method applies a radiant exposure which results in the damaging or altering of the retinal pigmented epithelium cells in such a manner as to trigger cellular responses which improve the hydraulic conductivity of Bruch's membrane without causing irreversible damage to adjacent retinal structures and layers.

Retinal regeneration

In a system for stabilizing a pattern of structural changes in corneal fibrils, an eye treatment system causes corneal fibrils of a cornea of an eye to transition from a first structure to a second structure. An application device applies a cross-linking element to the corneal fibrils. An activating device applies an initiating element to the corneal fibrils and activates the cross-linking element. The cross-linking element causes cross-linking in the corneal fibrils to preserve the second structure of the corneal fibrils. Another application device may apply a cross-linking breaker to the corneal fibrils. The cross-linking breaker halts or reverses at least partially the cross-linking in the corneal fibrils. Another activating device applies an initiating element to the corneal fibrils and activates the cross-linking breaker. Advantageously, the cross-linking breaker provides greater control over the amount and progress of cross-linking that occurs in the corneal fibrils.

Method for making structural changes in corneal fibrils

A diagnostic method is disclosed wherein the potential preserved visual acuity in the retina of a patient is determined from the amount of tissue connecting the inner and outer plexiform layers remaining in the retina.

Diagnostic method and apparatus for predicting potential preserved visual acuity

Growing community of inventors

Farnborough, United Kingdom

John Marshall